ANI PHARMACEUTICALS INC (ANIP) - Insider Holders & Insider Ownership

List of insiders holdings for ANI PHARMACEUTICALS INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1MERIDIAN VENTURE PARTNERS II LP
Meridian Venture Partners II GP L.P.
Meridian Venture Partners II Co.
Brown Robert E. JR
10% Owner
2025-08-22 08:00:221,034,570
0
1,034,570Form 13D
2SIMES STEPHEN M
Vice Chairman, President & CEO
2012-01-27 16:29:26800,000
202,267
1,002,267Form 4
3EDELMAN JOSEPH
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
PERCEPTIVE ADVISORS LLC
Cho Michael
10% Owner
2004-12-13 16:48:36709,819
0
709,819Form 13G
4EDELMAN JOSEPH
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
PERCEPTIVE ADVISORS LLC
10% Owner
2004-12-13 16:48:36709,819
0
709,819Form 13G
5Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
2026-03-02 17:59:46101,056
436,920
537,976Form 4
6Lalwani Nikhil
PRESIDENT & CEO
2026-03-10 16:09:20404,889
0
404,889Form 4
7MARSHBANKS TRACY
Director
2018-05-16 16:22:180
349,934
349,934Form 4
8DONENBERG PHILIP B
Sr VP of Finance, CFO, Secy
2012-01-27 16:33:48329,322
0
329,322Form 4
9RAYNOR DANIEL
Director
2018-03-19 16:54:290
289,003
289,003Form 4
10Gassert Chad
SVP - CORP. DEV. & STRATEGY
2026-03-02 17:58:2274,916
158,490
233,406Form 4
11PRZYBYL ARTHUR
President and CEO
2020-04-08 17:54:20190,309
0
190,309Form 4
12CAREY STEPHEN P.
SVP & CFO
2026-03-10 16:04:42180,393
0
180,393Form 4
13Snabes Michael C
Sr. VP of Medical Affairs
2012-01-27 16:37:45165,000
0
165,000Form 4
14LEHMAN LEAH M
VP, Product Development
2005-08-25 15:16:38150,000
0
150,000Form 4/A
15Marken James G.
SVP OPS & PROD DEV
2024-06-11 16:51:43117,829
0
117,829Form 4
16SHERWIN STEPHEN A
Director
2012-03-30 17:27:49111,760
0
111,760Form 4
17Mutz Christopher
HEAD OF RARE DISEASE
2026-03-13 17:28:4691,309
0
91,309Form 4
18Schrepfer Robert W
SVP - NEW BUS DEV & SPEC SALES
2021-03-29 20:11:2387,477
0
87,477Form 4
19SULLIVAN LOUIS W
Director
2012-03-30 17:38:2282,898
0
82,898Form 4
20Gutwerg Ori
SVP, GENERICS
2026-03-10 16:07:1281,468
0
81,468Form 4
21Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
2026-04-13 16:40:3678,890
0
78,890Form 4
22Jamnick Robert J.
VP, Quality & Product Develop.
2014-05-27 16:38:1177,701
0
77,701Form 4
23HO ANGELA
Director
2004-03-22 15:48:2972,137
0
72,137Form 4
24Arnold Charlotte C.
Vice President and CFO
2016-04-11 19:10:1662,298
0
62,298Form 4
25Walsh Patrick D
Director
2026-03-03 18:01:0452,405
0
52,405Form 4
26Davis Krista
SVP, CHIEF HR OFFICER
2026-03-10 16:06:3251,946
0
51,946Form 4
27ROSENOW EDWARD C III
Director
2012-03-30 17:31:0145,540
0
45,540Form 4
28KJAER PETER
Director
2010-04-02 16:26:5144,425
0
44,425Form 4
29Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
2026-03-13 17:28:4838,730
0
38,730Form 4
30NASH DAVID
Director
2023-05-24 16:31:1338,561
0
38,561Form 4
31HAUGHEY THOMAS
Director
2025-08-14 17:38:3836,521
0
36,521Form 4
32POTTS JOHN T JR
Director
2012-03-30 17:34:4127,657
2,924
30,581Form 4
33MANGANO ROSS J
Director
2014-09-16 16:40:5726,914
0
26,914Form 4
34TANNENBAUM RENEE P
Director
2025-12-09 18:09:4525,157
0
25,157Form 4
35BELL STEVEN J
VP Research & Pre-Clinical Dev
2005-08-25 15:32:2725,000
0
25,000Form 4/A
36Thoma Jeanne
Director
2025-08-20 16:42:0323,405
0
23,405Form 4
37Pera Antonio R
Director
2025-09-04 16:44:5822,660
0
22,660Form 4
38Penn Thomas A.
Director
2019-04-01 16:00:2116,710
0
16,710Form 4
39HOLUBOW FRED
Director
2018-03-22 17:00:3516,144
0
16,144Form 4
40Leonard Matthew J
Director
2025-08-26 18:19:516,864
0
6,864Form 4
41LANKAU PETER A
Director
2016-04-11 18:58:164,500
0
4,500Form 4
42MORGENSTERN VICTOR A
Director
2007-06-14 16:53:130
0
0Form 4